From Propaganda to scientific marketing: Schering, cortisone, and the construction of drug markets

By Gaudillière Jean-Paul  

History and Technology, Vol. 29, Iss. 2, 2013-06 ,pp. : 188-209

Routledge Ltd

Access to resources Recommend Favorite

‘The Strophanthin question’: early scientific marketing of cardiac drugs in two national markets (France and Germany, 1900–1930)

By Bonah Christian  

History and Technology, Vol. 29, Iss. 2, 2013-06 ,pp. : 135-152

Routledge Ltd

Access to resources Recommend Favorite

Standardizing selling. Pharmaceutical marketing, the pharmaceutical company and the marketing expert (1900–1980)

By Thoms Ulrike  

History and Technology, Vol. 29, Iss. 2, 2013-06 ,pp. : 169-187

Routledge Ltd

Access to resources Recommend Favorite

A different mode of marketing? The importance of scientific articles in the marketing process of Salvarsan

By Hüntelmann Axel C.  

History and Technology, Vol. 29, Iss. 2, 2013-06 ,pp. : 116-134

Routledge Ltd

Access to resources Recommend Favorite

‘Doriden von Ciba’: sleeping pills, pharmaceutical marketing, and Thalidomide, 1955–1963

By Kessel Nils  

History and Technology, Vol. 29, Iss. 2, 2013-06 ,pp. : 153-168

Routledge Ltd

Access to resources Recommend Favorite